Literature DB >> 14682663

Attachment of periodontal ligament cells to chlorhexidine-loaded guided tissue regeneration membranes.

Yen-Ting Chen1, Shan-Ling Hung, Li-Wen Lin, Lin-Yang Chi, Li-Jane Ling.   

Abstract

BACKGROUND: Early exposure of a guided tissue regeneration (GTR) membrane in the oral cavity results in bacterial contamination, which may lead to failure or incomplete regeneration. Incorporation of antimicrobial agents in GTR membranes may be valuable to control membrane-associated infection during GTR therapy. The purpose of this study was to evaluate whether the incorporation of chlorhexidine into various GTR membranes improves the attachment of periodontal ligament cells in the presence of Actinobacillus actinomycetemcomitans.
METHODS: The possible effects of chlorhexidine on the viability of primary human periodontal ligament (PDL) cells were determined using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide (MTT), which measures cellular metabolic activity. An expanded polytetrafluoroethylene (ePTFE) membrane, glycolide fiber membrane, and collagen membrane were loaded with chlorhexidine and characterized. Attachment of PDL cells to the chlorhexidine-loaded membranes with or without A. actinomycetemcomitans was examined using scanning electron microscopy (SEM) analysis.
RESULTS: Relative cellular viability of PDL cells was reduced to approximately 50% when 15 microg/ml (0.0015%) of chlorhexidine was used. Chlorhexidine released from the coated GTR membranes inhibited the growth of A. actinomycetemcomitans. At the concentration used in this study, chlorhexidine incorporated into the GTR membranes did not interfere with the attachment of PDL cells. The inhibitory effects of A. actinomycetemcomitans on cellular attachment were reduced using chlorhexidine-loaded membranes, including ePTFE, glycolide fiber, and collagen membranes.
CONCLUSIONS: These results suggest that incorporation of chlorhexidine into GTR membranes is beneficial in reducing bacterial effects on cellular attachment. The future application of chlorhexidine-loaded membranes during GTR therapy may be of value.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14682663     DOI: 10.1902/jop.2003.74.11.1652

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  6 in total

1.  In vitro comparison of chlorhexidine and povidone-iodine on the long-term proliferation and functional activity of human alveolar bone cells.

Authors:  Cristina Trigo Cabral; Maria Helena Fernandes
Journal:  Clin Oral Investig       Date:  2007-01-11       Impact factor: 3.606

2.  Fabrication and anti-microbial evaluation of drug loaded polylactide space filler intended for ridge preservation following tooth extraction.

Authors:  Nebu George Thomas; George P Sanil; Gopimohan Rajmohan; Jayachandran V Prabhakaran; Amulya K Panda
Journal:  J Indian Soc Periodontol       Date:  2011-07

3.  PDGF-metronidazole-encapsulated nanofibrous functional layers on collagen membrane promote alveolar ridge regeneration.

Authors:  Ming-Hua Ho; Hao-Chieh Chang; Yu-Chia Chang; Jeiannete Claudia; Tzu-Chiao Lin; Po-Chun Chang
Journal:  Int J Nanomedicine       Date:  2017-08-02

4.  In-vitro antibiofilm activity of chlorhexidine digluconate on polylactide-based and collagen-based membranes.

Authors:  Jan-Luca Rudolf; Corina Moser; Anton Sculean; Sigrun Eick
Journal:  BMC Oral Health       Date:  2019-12-26       Impact factor: 2.757

Review 5.  Antibiotic-Loaded Polymeric Barrier Membranes for Guided Bone/Tissue Regeneration: A Mini-Review.

Authors:  Manuel Toledano-Osorio; Cristina Vallecillo; Marta Vallecillo-Rivas; Francisco-Javier Manzano-Moreno; Raquel Osorio
Journal:  Polymers (Basel)       Date:  2022-02-21       Impact factor: 4.329

6.  Biocompatibility and cytotoxic evaluation of drug-loaded biodegradable guided tissue regeneration membranes.

Authors:  Nebu G Thomas; George P Sanil; Rajmohan Gopimohan; Jayachandran V Prabhakaran; George Thomas; Amulya K Panda
Journal:  J Indian Soc Periodontol       Date:  2012-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.